Literature DB >> 8621691

Structural studies on folding intermediates of serine hydroxymethyltransferase using single tryptophan mutants.

K Cai1, V Schirch.   

Abstract

Previous studies showed that during the in vitro folding of Escherichia coli serine hydroxymethyltransferase at 4 degrees C, both monomer and dimer intermediates accumulated and were stable for periods of minutes to hours (Cai, K., Schirch, D., and Schirch, V.(1995) J. Biol. Chem. 270, 19294-19299). To obtain structural information on these intermediates, two of the three Trp residues in the protein were changed to Phe to generate a set of three single Trp mutant enzymes. These mutant enzymes were purified and characterized and shown to retain essentially all of the properties of the wild-type enzyme. The fluorescence and circular dichroism measurements of each mutant enzyme were studied under unfolding-refolding equilibrium conditions and during refolding. In addition, the sensitivity of the protein to digestion by subtilisin during refolding was investigated. The results of these studies show that the unfolded enzyme has two domains that rapidly fold to form a monomer in which the first 55 amino acids and a segment between residues 225 and 276 remain in a largely disordered form. This partially folded enzyme can form dimers and slowly undergoes a rate determining conformational change in which the unstructured segments assume their native state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621691     DOI: 10.1074/jbc.271.6.2987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  The mechanism of addition of pyridoxal 5'-phosphate to Escherichia coli apo-serine hydroxymethyltransferase.

Authors:  Francesca Malerba; Andrea Bellelli; Alessandra Giorgi; Francesco Bossa; Roberto Contestabile
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

Review 2.  Extremophilic SHMTs: from structure to biotechnology.

Authors:  Sebastiana Angelaccio
Journal:  Biomed Res Int       Date:  2013-06-13       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.